UK coronavirus vaccine candidate is safe and effective with few side effects, early trial results show
Two candidate vaccines, including a closely watched one being developed at the University of Oxford, showed positive trial results Monday against the virus that causes COVID-19, making it more likely that a safe, effective vaccine can be developed quickly.
Early stage trials only explore safety and dosing and cannot determine a vaccine's effectiveness, but signs indicate that all four candidate vaccines are leading to immune responses similar to those experienced by people infected with the SARS-CoV-2 virus.new results showed Oxford University Half the volunteers were given the SARS-CoV-2 vaccine and half were given a meningitis vaccine. The so-called AZD-1222 vaccine caused more side effects considered minor than the meningitis one, but acetaminophen relieved most of the effects, the study found.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Promising Sign As Coronavirus Vaccine Developed By AstraZeneca And Oxford University Appears Safe, Early Trials ShowThe vaccine is still in early-stage clinical trials, and it is yet to be seen whether it can protect people against the virus.
Read more »
Oxford University, AstraZeneca Covid-19 Vaccine Front-Runner Shows Promise in TrialsA leading coronavirus-vaccine candidate being developed by University of Oxford researchers and AstraZeneca showed positive results in early trials, according to published results, raising the prospect that a shot could be available by the end of this year.
Read more »
Coronavirus vaccine from Oxford and AstraZeneca shows positive response in early trialA potential coronavirus vaccine developed by Oxford University in the U.K. has produced an immune response in an early-stage human trial, according to newly released data published Monday in medical journal The Lancet.
Read more »
Oxford coronavirus vaccine generates promising Phase 1/2 results: StudyA team of scientists at the University of Oxford released promising results showing their COVID-19 vaccine appears safe in an early-stage study — welcome news for one of the most advanced vaccine programs in the world. The Phase 1/2 results, published Monday in the scientific journal The Lancet, also
Read more »
Oxford coronavirus vaccine generates promising Phase 1/2 results: Study
Read more »
UK coronavirus vaccine prompts immune response in early testLONDON (AP) — Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the...
Read more »